Guideline-Directed Low-Density Lipoprotein Cholesterol Management After Acute Ischemic Stroke: Findings from a National Health Care Service
Patients with ischemic stroke are at high risk for future cardiovascular events and should be treated intensively with lipid-modifying agents. Combination lipid-lowering therapies are often needed to achieve updated guideline-directed treatment goals. However, real-world data on intensification of lipid-lowering therapies and attainment of low-density lipoprotein cholesterol (LDL-C) targets early after ischemic stroke are limited. We extracted data from the largest healthcare provider in Israel on patients hospitalized with acute ischemic stroke between January 2020 and February 2022.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Barak Zafrir, Amir Aker, Ibrahim Naoum, Walid Saliba Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Health Management | Heart | Ischemic Stroke | Israel Health | Middle East Health | Stroke